The Tobacco Regulatory Science Program (TRSP) is an interagency partnership between the NIH and the FDA Center for Tobacco Products to foster tobacco regulatory research.
With the passage of the 2009 Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act), the FDA acquired the authority to regulate the manufacture, marketing, and distribution of tobacco products in order to protect public health. Within the framework of the Tobacco Control Act, the NIH and FDA formed this partnership to establish a comprehensive research agenda in tobacco regulatory science.
Current K, R01, and R21 funding announcements for career development awards, secondary analysis of existing datasets and biospecimens, and pharmacokinetics of tobacco products. Frequently asked questions and recorded pre-application webinars are available for select funding opportunities.
These FAQs clarify research that is and is not within scope of the FDA’s Center for Tobacco Products (CTP) regulatory authority. Only research that is within the regulatory authority of the FDA CTP will be considered for funding.
This special issue of Nicotine & Tobacco Research, developed by TRSP-funded researchers, includes a collection of multidisciplinary studies that begin to examine the effect of tobacco and nicotine use from the cellular level to patterns of use and symptomology at the population level.
An NIH-FDA partnership to foster tobacco regulatory research.
Research projects on tobacco regulatory research funded through TRSP.
Active funding announcements and application information.
Research topic and project priorities for TRSP funding announcements.
Research tools, publications, statistics, and announcements.